Back
4D Molecular Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
11
FDMT
4D Molecular Therapeutics
Last Price:
11.61
Seasonality Move:
44.72%
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
0.72
Seasonality Move:
-14.79%
Sell
11
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $11.90. The Score for FDMT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $11.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.74
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 29.9 | Sell |
Chaikin Money Flow: | -1643591 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.24 - 16.18) | Sell |
Bollinger Bands (100): | (15.64 - 24.8) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 61.79 | Buy |
Chaikin Money Flow: | -53331864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.57) | Buy |
Bollinger Bands (100): | (0.56 - 3.36) | Sell |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.34 | Sell |
20-day SMA: | 15.32 | Sell |
50-day SMA: | 16.36 | Sell |
200-day SMA: | 22.25 | Sell |
8-day EMA: | 14.73 | Sell |
20-day EMA: | 15.25 | Sell |
50-day EMA: | 16.73 | Sell |
200-day EMA: | 19.97 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.52 | Buy |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.83 | Sell |
200-day SMA: | 3.74 | Sell |
8-day EMA: | 0.55 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.94 | Sell |
200-day EMA: | 8.27 | Sell |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.31 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
4D Molecular Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |